Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Galileo Life Sciences is a healthcare and life sciences holding company that focuses on acquiring and developing innovative assets in the biotechnology and wellness sectors. Formerly known as Modern Biosciences, the company operates as a platform for identifying high-potential medical technologies and therapeutic candidates. Its business model involves the strategic management of a portfolio of subsidiaries and licensed technologies aimed at addressing unmet medical needs in oncology and infectious diseases. Galileo Life Sciences seeks to bridge the gap between early-stage research and commercialization through targeted investments and operational support.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Galileo Fund Management.